Ads
related to: macular degeneration research- Clinical Study Results
See The Results of A Clinical Study
To Learn More About This Treatment
- Wet AMD FAQs
Get Answers To Frequently Asked
Questions About Wet AMD
- Financial Assistance
Learn About Financial Support
That May Be Available To You
- Download The Amsler Grid
Use This Test To Help Monitor
Your Vision Between Appointments
- Resource Library
Tools To Understand Your Condition
Financial Support, and More
- Appointment Tips
Get Tips And Useful Information
To Talk To Your Specialist
- Clinical Study Results
Search results
Results From The WOW.Com Content Network
The incidence of age-related macular degeneration and its associated features increases with age and is low in people <55 years of age. [101] Smoking is the strongest modifiable risk factor. [102] As of 2008, age-related macular degeneration accounts for more than 54% of all vision loss in the white population in the US. [103]
BrightFocus Foundation is a nonprofit organization based in Clarksburg, Maryland.BrightFocus funds research in an effort to discover cures for Alzheimer's disease, macular degeneration and glaucoma, and provides information and free English and Spanish resources to increase awareness about these diseases.
Macular degeneration is an incurable eye condition that affects the retina. It comes in two forms: wet and dry. Generally, medications can help with age-related macular degeneration, or AMD.
The Age-Related Eye Disease Study (AREDS) was a clinical trial sponsored by the National Eye Institute that ran from 1992 to 2001. [1] The study was designed to: investigate the natural history and risk factors of age-related macular degeneration (AMD) and cataracts, and
Foundation-funded scientists at institutions throughout the world conduct research for the entire spectrum of retinal degenerative diseases including: retinitis pigmentosa, macular degeneration, Usher syndrome, Stargardt disease, Best disease, choroideremia, retinoschisis, Leber congenital amaurosis, Bardet–Biedl syndrome, cone dystrophy, cone-rod dystrophy, rod–cone dystrophy ...
Induced pluripotent stem cell taken from blood cell and converted in retinal pigment epithelium. Stem cell therapy for macular degeneration is an emerging treatment approach aimed at restoring vision in individuals suffering from various forms of macular degeneration, particularly age-related macular degeneration (AMD). [1]
Ad
related to: macular degeneration research